Department of Plastic and Reconstructive Surgery, Korea University College of Medicine, Inchon-ro 73, Seongbuk-gu, Seoul, 02841, Republic of Korea.
Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Aesthetic Plast Surg. 2020 Dec;44(6):1997-2007. doi: 10.1007/s00266-020-01889-7. Epub 2020 Sep 16.
Aquafilling filler is used for breast and buttock augmentation, which are the most commonly performed cosmetic surgery procedures. However, complications after using Aquafilling filler for breast augmentation have been reported, and there are concerns regarding its use in large areas, such as the buttocks. We provide our experience with complications after breast augmentation and buttock augmentation using Aquafilling filler.
This observational cohort study analyzed the data of 399 patients treated for filler-related complications at our institutes from September 2015 to November 2019. Of these patients, 146 underwent surgery to remove Aquafilling filler from the breast or buttock.
The mean time between Aquafilling filler use and complication onset was 38.5 ± 10.2 months. The average amount of filler material removed from one side of the breast or buttock was 285.5 ± 95.8 mL (range 150-750 mL). The most common complications were induration and masses (83.6%), followed by pain (52.1%), firmness (24.7%), asymmetry (10.3%), migration (8.2%), mastitis (6.8%), dimpling (6.2%), fever (3.4%), and sepsis (n = 1). After treatment, there was no recurrence of infection, and the patient satisfaction level based on the visual analogue scale was 8.0 ± 0.9.
Although Aquafilling filler is easily injectable and has long-term clinical effects, complications can occur. Furthermore, there are concerns regarding its toxicity and influence on the surrounding tissues. Hence, further research studies on Aquafilling filler and evidence regarding its long-term safety are needed.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
水凝胶（Aquafilling）填充物用于隆胸和丰臀，这是最常进行的美容手术。然而，已有关于使用水凝胶填充物隆胸后出现并发症的报道，并且对于在臀部等大面积使用该填充物存在担忧。我们提供了我们在使用水凝胶填充物隆胸和丰臀后出现并发症方面的经验。
本观察性队列研究分析了我们机构自 2015 年 9 月至 2019 年 11 月期间治疗填充物相关并发症的 399 名患者的数据。其中 146 名患者接受了手术，以从乳房或臀部取出水凝胶填充物。
从使用水凝胶填充物到出现并发症的平均时间为 38.5±10.2 个月。从一侧乳房或臀部取出的填充物平均量为 285.5±95.8 毫升（范围 150-750 毫升）。最常见的并发症是硬结和肿块（83.6%），其次是疼痛（52.1%）、硬结（24.7%）、不对称（10.3%）、移位（8.2%）、乳腺炎（6.8%）、凹陷（6.2%）、发热（3.4%）和败血症（n=1）。治疗后，无感染复发，基于视觉模拟量表的患者满意度为 8.0±0.9。
尽管水凝胶填充物易于注射且具有长期的临床效果，但仍可能出现并发症。此外，人们对其毒性及其对周围组织的影响存在担忧。因此，需要进一步研究水凝胶填充物，并获得其长期安全性的证据。
证据等级 IV：本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学等级的完整描述，请参考目录或在线作者指南 www.springer.com/00266 。
